Cargando…
STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
Constitutive activation of STAT3 is a common feature in many solid tumors including non-small cell lung carcinoma (NSCLC). While activation of STAT3 is commonly achieved by somatic mutations to JAK2 in hematologic malignancies, similar mutations are not often found in solid tumors. Previous work has...
Autores principales: | Looyenga, Brendan D., Hutchings, Danielle, Cherni, Irene, Kingsley, Chris, Weiss, Glen J., MacKeigan, Jeffrey P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271110/ https://www.ncbi.nlm.nih.gov/pubmed/22319590 http://dx.doi.org/10.1371/journal.pone.0030820 |
Ejemplares similares
-
Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2013) -
Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2014) -
Leaving the lysosome behind: novel developments in autophagy inhibition
por: Solitro, Abigail R, et al.
Publicado: (2016) -
Persistent Mitochondrial Hyperfusion Promotes G2/M Accumulation and Caspase-Dependent Cell Death
por: Westrate, Laura M., et al.
Publicado: (2014) -
Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
por: Lodewijckx, Inge, et al.
Publicado: (2021)